Citi and Stifel Adjust Medtronic Outlook Following MiniMed IPO
Citi has cut its target for Medtronic (MDT), while Stifel has lowered its outlook for the company, following the recent MiniMed IPO.
Results for "MiniMed"
14 stories found
US Gas Prices Hit $4 a Gallon Amid Iran War Disruptions and Continue to Rise
Gas prices in the US have eclipsed $4 a gallon, reaching their highest level since 2022 and continuing to rise rapidly, as the Iran war disrupts global energy supply through the Strait of Hormuz.
MiniMed gets FDA clearance for MiniMed Flex, its smallest smartphone-controlled insulin pump
MiniMed IPO and MMED Stock Performance
Investors are evaluating whether to buy MMED stock following the recent initial public offering of MiniMed.
Medtronic's MiniMed Diabetes Unit Eyes $7.9 Billion Valuation in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking a valuation of $7.9 billion as it prepares for a US initial public offering.
Stifel Cuts Medtronic (MDT) Target to $95 Citing MiniMed IPO Effects
Stifel has lowered its price target for Medtronic (MDT) to $95, attributing the adjustment to the anticipated effects of the MiniMed IPO.
MiniMed Initiated with 'Buy' Rating by Bank of America
Bank of America has initiated coverage of MiniMed with a 'Buy' rating, citing a positive outlook driven by the company's pipeline of products and potential for growth.
Medtronic's Diabetes Unit MiniMed Stock Drops on Debut
Medtronic's diabetes unit, MiniMed, experienced a decline in its stock value on its trading debut.
Medtronic's MiniMed Diabetes Business Seeks $784M in US IPO
Medtronic's diabetes business unit, MiniMed, is reportedly planning an Initial Public Offering (IPO) in the United States, aiming to raise $784 million.
Medtronic's MiniMed Diabetes Unit Seeks Up to $784M in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking to raise up to $784 million through an initial public offering (IPO) in the U.S. market.
Wall Street Analysts Issue Diverse Research Calls Across Multiple Sectors, Including Grab Holdings
Wall Street analysts have released a range of research calls, including updates on Scotts Miracle-Gro, Colgate-Palmolive, Townsquare Media, Concentrix, Oxford Industries, Dime Community Bancshares, Buckle, UDR, Mid-America Apartment Communities, Winnebago, BankUnited, Smithfield Foods, THOR Industries, JPMorgan Chase, and a 'Buy' rating for Grab Holdings from Barclays.
Medtronic Lowers 2026 Earnings Outlook Following MiniMed Updates
Medtronic has revised its earnings outlook for 2026 downwards, attributing the change to recent updates concerning its MiniMed products.
Medtronic Subsidiary MiniMed Prices $560M IPO at $20 Per Share
MiniMed, a subsidiary of Medtronic, has priced its initial public offering of $560 million at $20 per share.
Medtronic MiniMed Seeks $784 Million in US IPO
Medtronic's diabetes unit, MiniMed, is reportedly seeking $784 million in its upcoming US Initial Public Offering.